Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Teva
Fish and Richardson
Accenture
Harvard Business School
Merck
Cerilliant
Cantor Fitzgerald
US Department of Justice

Generated: May 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,760,072

« Back to Dashboard

Summary for Patent: 4,760,072
Title: Solid nedocromil sodium, useful for the removal of obstructed air pathways
Abstract:There are described new forms of nedocromil sodium, methods of producing these new forms and pharmaceutical formulations, especially pressurized inhalation aerosol formulations, containing finely divided nedocromil sodium. The formulations are indicated for the treatment of reversible obstructive conditions of the airways.
Inventor(s): Brown; Kenneth (Loughborough, GB2), Clark; Andrew R. (Loughborough, GB2), Salliss; Richard (Holmes Chapel, GB2)
Assignee: Fisons, plc (Ipswich, GB2)
Application Number:06/720,588
Patent Claim Types:
see list of patent claims
Use; Formulation;

Drugs Protected by US Patent 4,760,072

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,760,072

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8409705Apr 13, 1984
United Kingdom8423634Sep 19, 1984

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
AstraZeneca
Moodys
Merck
Mallinckrodt
Dow
Medtronic
Teva
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.